Form 8-K - Current report:
SEC Accession No. 0001437749-25-020102
Filing Date
2025-06-11
Accepted
2025-06-11 17:24:18
Documents
15
Period of Report
2025-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20250606c_8k.htm   iXBRL 8-K 52121
2 EXHIBIT 10.1 ex_828340.htm EX-10.1 272582
3 EXHIBIT 10.2 ex_828359.htm EX-10.2 81648
  Complete submission text file 0001437749-25-020102.txt   626397

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20250611.xsd EX-101.SCH 3579
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20250611_def.xml EX-101.DEF 11807
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20250611_lab.xml EX-101.LAB 15858
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20250611_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250606c_8k_htm.xml XML 2933
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 251040953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)